Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01790789 · ClinicalTrials.gov registry record · NA
Stress Reduction in Ovarian Cancer
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01790789: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT01790789 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01790789, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of a stress reduction program on the quality of life of ovarian cancer patients during primary adjuvant chemotherapy.
Primary Outcome
Fatigue will be measured using the NIH PROMIS Cancer Fatigue survey instrument
Interventions
- OTHER Attention control
- BEHAVIORAL Daily stress reduction program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-12-06 |
| Phase | NA |
What the finished NCT01790789 record still lists
NCT01790789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Attention control is the first listed.
NCT01790789 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01790789 about?
NCT01790789 is a clinical study titled "Stress Reduction in Ovarian Cancer". The purpose of this study is to investigate the effects of a stress reduction program on the quality of life of ovarian cancer patients during primary adjuvant chemotherapy.
What is the current status of trial NCT01790789?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2013-02. Estimated completion is 2016-12-06.
What interventions are being tested in trial NCT01790789?
The interventions under investigation include: Attention control (OTHER), Daily stress reduction program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01790789?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01790789's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia